CereVasc's eShunt System Triumphs: Health Canada Approves STRIDE Clinical Trial Authorization CereVasc, Inc. receives critical Investigational Testing Authorization in Canada for their innovative eShunt System targeting normal pressure hydrocephalus, aimed at enhancing patient care.

CereVasc's eShunt System Triumphs: Health Canada Approves STRIDE Clinical Trial Authorization #Canada #Boston #CereVasc #eShunt #STRIDE_Trial